1-4 of 4
Daniel L. Molin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008

David Lavie, John Timmerman, Ramón García-Sanz, Won Seog Kim, Tae Min Kim, Abraham Avigdor, Daan Dierickx, Deepa Jagadeesh, Daniel L. Molin, Muhit Ozcan, Omur Gokmen Sevindik, Hayder Saeed, Yulia Sidi, Pallavi Pillai, Patricia Marinello, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 3082.
https://doi.org/10.1182/blood-2023-182119
Published: 2023
Journal Articles

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

Peter Borchmann, Alden Moccia, Richard Greil, Gundolf Schneider, Mark S. Hertzberg, Valdete Schaub, Andreas Huettmann, Felix Keil, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel L. Molin, Stefanie Kreissl, Justin Ferdinandus, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl
Journal: Blood
Blood (2023) 142 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2023-188720
Published: 2023
Journal Articles

Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial

Justin Ferdinandus, Gundolf Schneider, Alexander Fosså, Alden Moccia, Richard Greil, Mark S. Hertzberg, Josée M. Zijlstra, Peter Kamper, Daniel L. Molin, Andrea Kerkhoff, Sebastian Scholl, Yon-Dschun Ko, Max S. Topp, Joachim Beck, Vladan Vucinic, Wolfram Jung, Roland Schroers, Andreas Rank, Carla Damaschin, Anne Sophie Jacob, Michael Fuchs, Peter Borchmann, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4437.
https://doi.org/10.1182/blood-2023-188449
Published: 2023
Journal Articles

Bleomycin Affects Lung Function for at Least 5 Years after Treatment for Hodgkin Lymphoma - Data from the International, Randomised Phase 3 Rathl Trial

Elizabeth H Phillips, Amy A Kirkwood, Christina Hague, Jorgen Vestbo, Massimo Federico, Francesco D'Amore, Alexander Fossa, Judith Trotman, Leanne Berkahn, Daniel L. Molin, Stefano Luminari, Sally F Barrington, Peter Johnson, John Radford
Journal: Blood
Blood (2023) 142 (Supplement 1): 612.
https://doi.org/10.1182/blood-2023-185818
Published: 2023